Pure Global

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers - Trial NCT06393907

Access comprehensive clinical trial information for NCT06393907 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Recruiting. The study focuses on Gastroduodenal Ulcer. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06393907
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06393907
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers
A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

Study Focus

Gastroduodenal Ulcer

Hemostatic Forceps

Interventional

device

Sponsor & Location

Mahidol University

Bangkok Noi, Thailand

Timeline & Enrollment

N/A

Mar 26, 2024

Apr 26, 2026

150 participants

Primary Outcome

Comparing hemostatic rate between hemostatic forceps and bipolar electrocautery probes

Summary

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar
 electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

ICD-10 Classifications

Gastric ulcer
Gastrojejunal ulcer
Gastric ulcer : chronic or unspecified with haemorrhage
Gastrojejunal ulcer : chronic or unspecified with haemorrhage
Gastrojejunal ulcer : unspecified as acute or chronic, without haemorrhage or perforation

Data Source

ClinicalTrials.gov

NCT06393907

Device Trial